Zhejiang Jingxin Pharmaceutical Co Ltd (002020) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a cash flow conversion efficiency ratio of 0.040x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥227.64 Million ≈ $33.31 Million USD) by net assets (CN¥5.69 Billion ≈ $831.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Jingxin Pharmaceutical Co Ltd (002020) liquidity interval to measure how many days the company can operate on defensive assets alone.
Zhejiang Jingxin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Zhejiang Jingxin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhejiang Jingxin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Jingxin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dynamic Holding Co. Ltd.
TW:3715
|
-0.034x |
|
Expro Group Holdings NV
NYSE:XPRO
|
0.017x |
|
Parade Technologies Ltd
TWO:4966
|
0.039x |
|
Five-Star Business Finance Limited
NSE:FIVESTAR
|
0.002x |
|
Argan SA
PA:ARG
|
0.037x |
|
Central Plaza Hotel Public Company Limited
BK:CENTEL
|
0.071x |
|
LANXESS Aktiengesellschaft
F:LXS
|
0.013x |
|
Israel Canada
TA:ISCN
|
-0.076x |
Annual Cash Flow Conversion Efficiency for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Jingxin Pharmaceutical Co Ltd from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see 002020 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥5.87 Billion ≈ $859.00 Million |
CN¥781.35 Million ≈ $114.34 Million |
0.133x | +10.01% |
| 2024-12-31 | CN¥6.00 Billion ≈ $878.21 Million |
CN¥726.16 Million ≈ $106.26 Million |
0.121x | -18.72% |
| 2023-12-31 | CN¥5.54 Billion ≈ $810.70 Million |
CN¥824.69 Million ≈ $120.68 Million |
0.149x | -10.04% |
| 2022-12-31 | CN¥5.17 Billion ≈ $756.82 Million |
CN¥855.78 Million ≈ $125.23 Million |
0.165x | +119.29% |
| 2021-12-31 | CN¥4.84 Billion ≈ $707.90 Million |
CN¥365.02 Million ≈ $53.41 Million |
0.075x | -42.18% |
| 2020-12-31 | CN¥3.93 Billion ≈ $575.47 Million |
CN¥513.21 Million ≈ $75.10 Million |
0.130x | -9.54% |
| 2019-12-31 | CN¥3.71 Billion ≈ $542.99 Million |
CN¥535.30 Million ≈ $78.33 Million |
0.144x | -1.51% |
| 2018-12-31 | CN¥3.57 Billion ≈ $522.90 Million |
CN¥523.40 Million ≈ $76.59 Million |
0.146x | +50.87% |
| 2017-12-31 | CN¥3.97 Billion ≈ $580.29 Million |
CN¥385.01 Million ≈ $56.34 Million |
0.097x | -6.78% |
| 2016-12-31 | CN¥2.43 Billion ≈ $355.06 Million |
CN¥252.69 Million ≈ $36.98 Million |
0.104x | +62.70% |
| 2015-12-31 | CN¥2.26 Billion ≈ $330.78 Million |
CN¥144.69 Million ≈ $21.17 Million |
0.064x | -57.47% |
| 2014-12-31 | CN¥1.40 Billion ≈ $204.65 Million |
CN¥210.49 Million ≈ $30.80 Million |
0.151x | +10.88% |
| 2013-12-31 | CN¥817.98 Million ≈ $119.70 Million |
CN¥111.03 Million ≈ $16.25 Million |
0.136x | +73.98% |
| 2012-12-31 | CN¥772.58 Million ≈ $113.05 Million |
CN¥60.28 Million ≈ $8.82 Million |
0.078x | -13.88% |
| 2011-12-31 | CN¥766.17 Million ≈ $112.11 Million |
CN¥69.41 Million ≈ $10.16 Million |
0.091x | -51.30% |
| 2010-12-31 | CN¥320.13 Million ≈ $46.84 Million |
CN¥59.55 Million ≈ $8.71 Million |
0.186x | -57.79% |
| 2009-12-31 | CN¥307.17 Million ≈ $44.95 Million |
CN¥135.38 Million ≈ $19.81 Million |
0.441x | +345.67% |
| 2008-12-31 | CN¥303.19 Million ≈ $44.37 Million |
CN¥29.98 Million ≈ $4.39 Million |
0.099x | +133.82% |
| 2007-12-31 | CN¥299.61 Million ≈ $43.84 Million |
CN¥-87.60 Million ≈ $-12.82 Million |
-0.292x | -5856.81% |
| 2006-12-31 | CN¥294.62 Million ≈ $43.11 Million |
CN¥-1.45 Million ≈ $-211.60K |
-0.005x | -102.30% |
| 2005-12-31 | CN¥289.64 Million ≈ $42.38 Million |
CN¥61.82 Million ≈ $9.05 Million |
0.213x | +842.74% |
| 2004-12-31 | CN¥284.03 Million ≈ $41.56 Million |
CN¥6.43 Million ≈ $940.95K |
0.023x | -95.66% |
| 2003-12-31 | CN¥88.44 Million ≈ $12.94 Million |
CN¥46.18 Million ≈ $6.76 Million |
0.522x | -27.68% |
| 2002-12-31 | CN¥63.02 Million ≈ $9.22 Million |
CN¥45.50 Million ≈ $6.66 Million |
0.722x | -- |
About Zhejiang Jingxin Pharmaceutical Co Ltd
Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemi… Read more